Trade War: Swiss want to make a new deal with US

US-Swiss Trade Relations & Tariffs - The US has imposed a 39% tariff on Switzerland, raising questions about the reasons behind it [1] - The 39% tariff does exempt pharmaceuticals [4] - The tariffs may be related to the Swiss franc being a haven currency as the dollar weakens [4] Pharmaceutical Industry Impact - Switzerland has a large pharmaceutical industry that exports significantly to the US [2] - The US is targeting pharmaceutical companies, including those based in Zurich like Novartis and Roche, to lower drug prices [3] - Trade tensions and potential tariffs could affect pharmaceutical companies with subsidiaries and businesses in the US [9] - Roche, a Swiss company, has a large American business called Genentech and is dealing with letters from the US government [9] - Novo Nordisk, a Danish company, is also at risk, as 60% of its revenue comes from the US [11] - Potential changes in Medicaid coverage and tariffs on drugs like Ozempic could significantly impact Novo Nordisk's revenue [12] Tourism & Economic Factors - A weaker dollar could make travel to Europe more expensive for Americans [6] - Business travel between the US and Europe has seen a slight decline [7]